About Warwick Medical School Clinical Trials Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Warwick Medical School Clinical Trials Unit
During the past decade, Warwick Medical School Clinical Trials Unit conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
2016-04-30
2022-12-13
Completed
578
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-08-10
2024-03-31
Active, not recruiting
135
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Warwick Medical School Clinical Trials Unit
According to Clinical.Site data, the most researched conditions in "Warwick Medical School Clinical Trials Unit" are
"Adenocarcinoma of the Gastroesophageal Junction" (1 trials), "Esophageal Cancer" (1 trials), "Gastric Cancer" (1 trials), "Head and Neck Cancer" (1 trials) and "Nausea and Vomiting" (1 trials). Many other conditions were trialed in "Warwick Medical School Clinical Trials Unit" in a lesser frequency.
Clinical Trials Intervention Types at Warwick Medical School Clinical Trials Unit
Most popular intervention types in "Warwick Medical School Clinical Trials Unit" are "Procedure" (2 trials), "Drug" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "docetaxel" (1 trials), "nausea and vomiting therapy" (1 trials), "pain therapy" (1 trials), "positron emission tomography/computed tomography" (1 trials) and "quality-of-life assessment" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Warwick Medical School Clinical Trials Unit
The vast majority of trials in "Warwick Medical School Clinical Trials Unit" are
2 trials for "All" genders.
Clinical Trials Status at Warwick Medical School Clinical Trials Unit
Currently, there are NaN active trials in "Warwick Medical School Clinical Trials Unit".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Warwick Medical School Clinical Trials Unit,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Warwick Medical School Clinical Trials Unit, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".